(Total Views: 422)
Posted On: 08/08/2021 2:30:57 PM
Post# of 36564
Hi Buildit, I wouldn’t know with any certainty. But keep in mind that Generex had a working relationship with PPD for well over a year to help Generex advance the Ii-Key-Sars-Cov-2 peptide vaccine. Joe said this in a press release in the Spring of 2020:
“We have contracted PPD, a recognized leading CRO to provide comprehensive, turnkey clinical and regulatory services, including regulatory submissions, site preparation, clinical testing, data management, protocols and reports required to maximize the speed and path to licensure.“
PPD had written a letter of support for Generex to BARDA.
So, with this new agreement with PPD, I’m hoping the CRO is preparing for a Phase I study.
“We have contracted PPD, a recognized leading CRO to provide comprehensive, turnkey clinical and regulatory services, including regulatory submissions, site preparation, clinical testing, data management, protocols and reports required to maximize the speed and path to licensure.“
PPD had written a letter of support for Generex to BARDA.
So, with this new agreement with PPD, I’m hoping the CRO is preparing for a Phase I study.
(3)
(0)
